Skip to main content
. 2011 Feb;46(1 Pt 1):61–81. doi: 10.1111/j.1475-6773.2010.01192.x

Table 1.

Unadjusted Average Process Compliance by Pay-for-Performance (P4P) and Public-Reporting-Only Hospitals, Fiscal Years 2003–2005

P4P Hospitals Reporting Early Adopters Public-Reporting Only



Year 1 Year 3 Gain Year 1 Year 3 Gain Year 1 Year 3 Gain
AMI easy composite 93.3 96.5 3.2 92.5 95.5 3.0 91.9 95.3 3.4
(4.8) (3.0) (6.1) (3.9) (6.7) (4.1)
Aspirin at arrival (E) 95.0 97.2 2.2 94.7 96.5 1.8 94.5 96.4 1.9
(4.3) (2.9) (5.1) (3.4) (5.1) (3.4)
Aspirin at discharge (E) 94.1 96.8 2.6 92.9 95.5 2.6 92.2 95.2 3.0
(6.6) (4.3) (8.1) (5.2) (9.1) (5.8)
β-Blockers at arrival (E) 79.6 88.5 8.8 89.9 93.6 3.7 78.2 85.3 7.1
(14.2) (10.7) (9.2) (5.5) (17.9) (11.6)
β-Blockers at discharge (E) 92.5 96.8 4.2 91.2 95.6 4.5 90.2 95.2 5.0
(6.8) (3.7) (8.8) (4.8) (9.6) (5.3)
ACE-inhibitors for LVSD (difficult measure) 90.7 94.9 4.2 79.2 86.0 6.7 89.1 93.4 4.3
(7.2) (4.3) (16.9) (11.2) (9.8) (5.6)
Heart failure (HF) easy composite 59.1 78.3 19.2 53.3 72.3 19.0 51.7 71.4 19.7
(24.8) (13.8) (25.4) (17.5) (26.3) (17.8)
Discharge instructions (E) 56.0 74.5 18.5 49.7 68.4 18.8 47.9 67.4 19.5
(27.0) (16.3) (26.9) (19.9) (28.0) (20.2)
Smoking cessation advice (E) 75.7 95.8 20.1 69.1 90.5 21.3 68.1 90.1 22.0
(20.8) (6.7) (26.3) (11.9) (26.8) (12.1)
HF difficult composite 86.2 93.5 7.3 85.0 91.6 84.3 91.1 6.8
(7.4) (4.8) (9.3) (5.4) (9.5) (5.9)
ACE-inhibitors for LVSD 89.0 95.5 6.4 88.1 94.0 6.0 87.3 93.5 6.2
(7.7) (4.6) (9.7) (5.4) (10.0) (6.1)
Left ventricular assessment 78.5 88.2 9.8 76.2 85.5 9.4 75.8 85.1 9.3
(12.2) (8.3) (14.0) (8.6) (14.2) (9.1)
Pneumonia easy composite 98.9 99.8 0.9 98.8 99.7 0.9 98.7 99.7 1.0
(2.1) (0.5) (2.7) (0.7) (2.6) (0.8)
Pneumonia vaccination status (E) 51.6 80.9 29.3 43.3 71.9 28.6 42.1 70.6 28.5
(24.3) (13.0) (25.8) (18.0) (25.5) (18.8)
Oxygenation assessment (E) 98.9 99.8 0.9 98.8 99.7 0.9 98.7 99.7 0.9
(2.1) (0.5) (2.7) (0.7) (2.6) (0.8)
Pneumonia difficult composite 66.2 83.8 17.6 63.7 79.2 15.5 63.2 78.6 15.4
(10.3) (6.9) (11.3) (9.2) (11.3) (9.4)
Blood culture preantibiotics 83.4 92.1 8.6 82.3 89.9 7.6 82.3 89.7 7.4
(7.8) (5.4) (9.5) (6.4) (9.8) (6.5)
Antibiotic timing 68.7 80.3 11.6 68.5 77.4 8.8 68.3 77.0 8.6
(9.5) (7.6) (11.6) (10.3) (11.6) (10.3)
% Medicare patient days 0.51 0.50 0.50
(0.11) (0.13) (0.13)
RN:patient ratio 0.02 0.02 0.02
(0.01) (0.01) (0.01)
Quality reporting 0.78 0.76
(0.41) (0.43)
Teaching hospital 0.38 0.28 0.27
(0.49) (0.45) (0.45)
Observations 145 842 1,089

Note. Standard deviations in parentheses. (E) indicates easy tasks. Summary statistics of process compliance for P4P and public-reporting-only hospitals reporting on at least 30 patients with targeted admissions annually. Public-reporting column includes early adopters.

AMI, acute myocardial infarction; LVSD, left ventricular systolic dysfunction; RN, registered nurse.